It’s been more than a year since Boehringer Ingelheim and Eli Lilly’s Jardiance became the first drug to score approvals for the two major types of heart failure (HF), opening a huge patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback